Search

Search Results

• PO:14:195 | Real-world effectiveness of anifrolumab in achieving treatment targets and reducing systemic lupus erythematosus disease burden: 6-month interim analysis of the REVEAL study Chiara Cardelli^1|2, Chiara Tani¹, Luca Moroni³, Filippo Vesentini⁴, Francesca Bottazzi⁵, Micaela Fredi⁶, Ettore Silvagni⁷, Matteo Piga⁸, Flavia Riccio⁹, Fulvia Ceccarelli¹⁰, Ginevra De Marchi¹¹, Edoardo Biancalana¹², Gianluca Moroncini¹³, Rita Mulè¹⁴, Mariele Gatto¹⁵, Laura Coladonato¹⁶, Paola Conigliaro¹⁷, Maria Gerosa¹⁸, Andrea Picchianti Diamanti¹⁹, Benedetta Bianchi²⁰, Federica Maiolini²⁰, Michela Gasparotto²⁰, Serena Guiducci²⁰, Maria Ilenia De Andres²⁰, Alberto Lo Gullo²⁰, Silvia Noviello²⁰, On Behalf Of The Reveal Investigators²⁰, Marta Mosca¹. | ¹Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa; ²Department of Medical Biotechnologies, University of Siena, Siena; ³Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milano; ⁴Rheumatology Unit, Department of Medicine, University of Padua, Padova; ⁵Department of Internal Medicine and Therapeutics, University of Pavia, Pavia; ⁶Rheumatology and Clinical Immunology, Department of Clinical and Experimental Sciences, University of Brescia, Brescia; ⁷Section of Rheumatology, Department of Medical Sciences, University of Ferrara; AOU Sant'Anna, Ferrara; ⁸Rheumatology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari;  ⁹Department of Precision Medicine, University of Campania Luigi Vanvitelli, Napoli; ¹⁰Rheumatology Unit, Dept. of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Roma; ¹¹Division of Rheumatology, Department of Medicine, Azienda Sanitaria Universitaria del Friuli Centrale, Udine; ¹²Internal Interdisciplinary Medicine Unit, Department of Experimental and Clinical Medicine, University of Florence, Firenze; ¹³Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona; ¹⁴Azienda Ospedaliero-Universitaria di Bologna, Internal Medicine and Rheumatology, IRCCS S. Orsola Malpighi, Bologna; ¹⁵Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin; AO Mauriziano, Torino; ¹⁶Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari; ¹⁷Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, Tor Vergata University of Rome, Roma; ¹⁸Clinical Rheumatology, ASST Gaetano Pini CTO; Department of Clinical Sciences and Community Health, University of Milano, Milano; ¹⁹Department of Clinical and Molecular Medicine, Sapienza University of Rome; AOU Sant'Andrea, Roma, Italy; ²⁰Italian REVEAL Study Group Italy, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2031

  146

• PO:16:227 | Anifrolumab for Systemic Lupus Erythematosus: Preliminary Safety and Efficacy Findings from the Italian Experience Paola Bizioli^1|2, Chiara Orlandi^1|2, Claudia Barison^1|2, Cesare Tomasi³, Alessia Caproli¹, Silvia Piantoni^1|2, Simona Signorini⁴, Emirena Garrafa⁴, Cecilia Nalli¹, Micol Frassi¹, Ilaria Cavazzana^1|2, Micaela Fredi^1|2, Franco Franceschini^1|2 | ¹Rheumatology and Clinical Immunology Unit - ERN ReCONNET, ASST Spedali Civili of Brescia, Italy; ²Department of Clinical and Experimental Sciences, University of Brescia, Italy; ³Department of Clinical and Experimental Sciences, University of Brescia, Italy; ⁴Laboratory of Clinical Chemistry, Department of Molecular and Translational Medicine, University of Brescia, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2333

  35

• PO:18:264 | Anifrolumab in Systemic Lupus Erythematosus: Bridging Clinical Trial Data with Real-World Evidence Giulia Cassone², Filippo Santoro¹, Caterina Vacchi², Dilia Giuggioli², Chiara Cabassi¹ | ¹UOC Reumatologia, AOU Policlinico di Modena, Università degli studi di Modena e Reggio Emilia Modena e Reggio Emilia, Italy; ²UOC Reumatologia, AOU Policlinico di Modena Modena, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2337

  54

• PO:08:126 | Use of upadacitinib in real-life: the experience of Calabrian rheumatology Vincenzo Raimondo¹, Maurizio Caminiti², Pietro Gigliotti³, Giuseppe Varcasia⁴, Massimo L'Andolina⁵, Domenico Olivo⁶, Roberta Pellegrini⁷, Pietro Muto⁸, Marilena Calabria⁹, Laura Massaro¹⁰, Jessica Maria El Luppino¹¹, Salvatore De Bonis¹², Giuseppa Pagano Mariano², Stefania Sorbara³, Virginia Caira⁴, Mariateresa Cirillo⁵, Caterina Bruno⁹, Clodoveo Ferri¹¹ | ¹UOC di Reumatologia, Dipartimento SCIAC, Sapienza Università di Roma; ²Dipartimento di Medicina, Clinica di Reumatologia, Università degli Studi di Udine; ³UOC Medicina Interna e Nefrologia, Dipartimento MeSVA, Università degli Studi di L'Aquila; ⁴UniCamillus, San Camillo Università Internazionale di Scienze della Salute di Roma, Italy; ⁵Ambulatorio di Reumatologia, Ospedale di Tropea, Tropea, Italy; ⁶ASP Crotone, Ambulatorio di Reumatologia, Crotone, Italy; ⁷Ambulatorio di Reumatologia, Ospedale Annunziata di Cosenza, Cosenza, Italy; ⁸Ambulatorio di Reumatologia, Ospedale di Paola, Paola, Italy; ⁹Ambulatorio di Reumatologia, SOC di Medicina Interna, AOU Dulbecco, Catanzaro, Italy; ¹⁰Ambulatorio di Reumatologia, Ospedale di Praia a Mare, Praia a Mare, Italy; ¹¹Casa di Cura Madonna dello Scoglio, Reparto di Reumatologia, Cotronei, Italy - Affiliazione 12: Ambulatorio di Reumatologia, ospedale di Acri, Acri, Italy  

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2143

  128

• PO:02:025 | Real-World Comparative Effectiveness of Upadacitinib in Psoriatic Arthritis: Evaluation of Switching to Upadacitinib Versus Tumor Necrosis Factor Inhibitors or Interleukin-17 Inhibitors After First-Line Tumor Necrosis Factor Inhibitors Valentina Carlini¹, Philip Mease², William Tillett³, Xiaolan Ye⁴, Christopher Saffore⁴, Molly Edwards⁵, Isabel Truman⁵, Sophie Barlow⁵, Jayne Stigler⁴, Bhumik Parikh⁴, Daniel Aletaha⁶ | ¹Abbvie srl Roma, Italy; ²University of Washington School of Medicine Seattle, United States Minor Outlying Islands; ³Department of Rheumatology, Royal National Hospital for Rheumatic Diseases Bath, United Kingdom; ⁴Abbvie Inc. North Chicago, United States Minor Outlying Islands; ⁵Adelphi Real World Bollington, United Kingdom; ⁶Division of Rheumatology, Department of Medicine, Medical University of Vienna, Vienna, Austria

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2286

  14

• CO:02:2 | Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis: real world data from an Italian National Registry Valerio Fiorilli¹, Francesca Romana Spinelli¹, Florenzo Iannone², Chiara Bazzani³, Alberto Cauli⁴, Rosario Foti⁵, Marcello Govoni⁶, Francesco Paolo Cantatore⁷, Fabiola Atzeni⁸, Roberto Caporali⁹, Marco Sebastiani¹⁰, Roberta Ramonda¹¹, Serena Bugatti¹², Elisa Gremese¹³, Maria Sole Chimenti¹⁴, Bruno Frediani¹⁵, Maurizio Rossini¹⁶, Angelo Semeraro¹⁷, Leonardo Santo¹⁸, Gianfranco Ferraccioli¹⁹, Giovanni Lapadula²⁰, Fabrizio Conti¹. | ¹Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma; ²Dipartimento di Medicina di Precisione e Rigenerativa e Area Jonica, Università degli Studi Aldo Moro, Bari; ³ASST Spedali Civili di Brescia, Unità di Reumatologia ed Immunologia Clinica, Brescia; ⁴Dipartimento di Scienze Mediche e Sanità Pubblica, Università degli Studi di Cagliari; ⁵A.O.U. Policlinico S. Marco, UOS Reumatologia, Catania; ⁶Dipartimento di Scienze Mediche, Università di Ferrara; ⁷Unità di Reumatologia,  Dipartimento di Medicina Specialistica, Università di Foggia; ⁸Dipartimento di Medicina Interna e Terapia Medica, UOC di Reumatologia, Università di Messina; ⁹Dipartimento di Scienze Cliniche e di Comunità, Università di Milano; ¹⁰Dipartimento di Medicina e Chirurgia, Università di Parma; ¹¹Unità di Reumatologia, Dipartimento di Medicina, Università di Padova; ¹²Dipartimento di Medicina Interna e Terapia Medica, Università di Pavia, ; ¹³IRCCS Istituto Clinico Humanitas, Dipartimento di Scienze Biomediche, Milano; ¹⁴Dipartimento di Medicina dei Sistemi, Università degli Studi di Roma-Tor Vergata, ; ¹⁵Dipartimento di Medicina Clinica e Scienze Immunologiche, Università di Siena; ¹⁶Dipartimento di Medicina, Università di Verona; ¹⁷Presidio Ospedaliero Valle d'Itria, Unità Operativa di Reumatologia, Martina Franca; ¹⁸Presidio Ospedaliero "Mons. Dimiccoli", Unità Operativa Semplice di Reumatologia, Barletta; ¹⁹Gruppo Italiano di Studio sulla Early Arthritis, GISEA, Roma; ²⁰Gruppo Italiano di Studio sulla early Arthritis, GISEA, Bari, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1966

  166

• PO:35:219 | Real-world effectiveness of mepolizumab on gastrointestinal involvement in eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome: a multicentre retrospective study Alessia Gatti¹, Francesca Regola¹, Giulia Fontana¹, Mario Addrea Piga², Gianluca Moroncini², Palma Carlucci³, Angelo Vacca³, Paolo Delvino⁴, Enrico Heffler⁵, Emanuele Nappi⁵, Jakub Moll⁶, Laura Losappio⁶, Jan Schroeder⁶, Federica Davanzo⁷, Roberto Padoan⁷, Edoardo Conticini⁸, Paolo Cameli⁸, Greta Pacini⁹, Alvise Berti⁹, Lorenzo Vrola¹⁰, Paola Tomietto¹⁰, Luca Quartuccio¹¹, Jan Willem Cohen Tervaert¹², Sabrina Arnold¹³, Peter Lamprecht¹³, Florence Roufosse¹⁴, Ilaria Cavazzana¹, Franco Franceschini¹, Giacomo Emmi¹⁵, Paola Toniati¹. | ¹Rheumatology and Clinical Immunology Unit, ERN ReCONNET, ASST Spedali Civili of Brescia and University of Brescia, Italy, Brescia, Italy; ²Università Politecnica delle Marche and Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy, Ancona, Italy; ³Section of Internal Medicine 'Guido Baccelli', DiMePRe-J, University of Bari 'Aldo Moro', Bari, Italy, Bari, Italy; ⁴Rheumatology Unit, IRCCS San Gerardo dei Tintori, Monza, Italy Monza Italy; ⁵Department of Biomedical Sciences, Humanitas University and Personalized Medicine, Asthma and Allergy IRCCS Humanitas, Milano, Italy; ⁶Division of Allergy and Clinical Immunology, ASST GOM Niguarda, Milan, Italy, Milano, Italy; ⁷Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padova, Italy, Padova, Italy; ⁸University of Siena, Siena, Italy, Siena, Italy; ⁹Santa Chiara Hospital and University of Trento, Unit of Rheumatology, Trento, Italy Trento Italy; ¹⁰UCO Medicina Clinica, ASUGI, Cattinara Teaching Hospital, Trieste, Italy, Trieste, Italy; ¹¹Division of Rheumatology, Department of Medicine ^DMED, University of Udine, Udine, Italy, Udine, Italy; ¹²University of Alberta, Edmonton, Alberta, Canada and Maastricht University, Maastricht, The Netherlands Maastricht The Netherlands; ¹³Department of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, Germany Lubeck Germany; ¹⁴Department of Internal Medicine, Hôpital Universitaire de Bruxelles - Erasme, Université Libre de Bruxelles, Belgium Brussels Belgium; ¹⁵Clinical Medicine and Clinical Immunology and Rheumatology Unit Cattinara University Hospital and University of Trieste, Trieste, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2086

  170

• CO:05:4 | Natural language processing reveals demographic features, comorbidities, and clinical domains to predict treatment longevity of b/tsDMARDs in psoriatic arthritis Antonio Tonutti^1|2, Pierandrea Morandini³, Cosimo Faeti³, Nicoletta Luciano^1|2, Saverio D'Amico³, Victor Savevski³, Carlo Selmi^1|2 | ¹Department of Biomedical Sciences, Humanitas University Pieve Emanuele, Milan, Italy; ²Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy; ³Artificial Intelligence Unit, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2275

  20

• PO:07:108 | Achievement of Treatment Targets and Maintenance of Response with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in a Real-world Setting: Final 2-year Outcomes from the UPHOLD Study Enrico Marchetta¹, Andrew Östör^2|8, Eugen Feist³, Prodromos Sidiropoulos⁴, Jérôme Avouac⁵, Martin Rebella^6|7, Rajaie Namas⁹, Erin Mcdearmon Blondell¹⁰, Ivan Lagunes¹⁰, Tianming Gao¹⁰, Tim Shaw¹⁰, Suzan Attar¹¹ | ¹AbbVie Srl Roma, Italy; ²Monash University and Emeritus Research, Melbourne, Victoria, Melbourne, Australia; ³Helios Department of Rheumatology and Clinical Immunology, Vogelsang-Gommern, Vogelsang Gommern, Germany; ⁴Faculty of Medicine, University of Crete, Heraklion, Heraklion, Greece; ⁵Service de Rhumatologie, Hôpital Cochin, AP HP Centre Université Paris Cité, Parigi, France; ⁶Departamento de Medicina, Facultad de Medicina, Universidad de la República, Montevideo, Montevideo, Uruguay; ⁷Unidad de Enfermedades Autoinmunes Sistémicas, MUCAM, Montevideo, Montevideo, Uruguay; ⁸Australian National University, Camberra, Australia; ⁹Medical Subspecialties Institute, Division of Rheumatology, Cleveland Clinic Abu Dhabi, United Arab Emirates; ¹⁰AbbVie Inc., North Chicago, Illinois, United States of America Chicago, USA; ¹¹King Abdulaziz University, Jeddah, Saudi Arabia

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2306

  16

• PO:16:236 | Achieving a low disease activity state with a corticosteroid dose of 5 mg or less: observational study with anifrolumab in patients with systemic lupus erythematosus in Italy Alessandra Bortoluzzi¹, Fulvia Ceccarelli², Fabio Leo³, Paola Roccatagliata³, Chiara Tani⁴, Margherita Zen⁵ | ¹Azienda Ospedaliera Universitaria Sant' Anna di Cona, Università di Ferrara Italy; ²Unità di Reumatologia, Università Sapienza Roma Italy; ³AstraZeneca S.p.a. Milano Italy; ⁴Università di Pisa e Azienda Ospedaliero Universitaria Pisana, Pisa Italy; ⁵Dipartimento di Medicina DIMED , Divisione di Reumatologia, Università di Padova, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2163

  110

• PO:01:003 | Sex-based differences in 2 years treatment outcomes with b/ts-DMARDs in psoriatic arthritis: from real-world evidence to predictive modeling from the Gruppo Italiano Studio Early Arthritis (GISEA) prospective registry Simone Perniola¹, Florenzo Iannone¹, Francesco Paolo Cantatore², Angelo Semeraro³, Leonardo Santo⁴, Roberto Gorla⁵, Alberto Cauli⁶, Roberto Felice Caporali⁷, Bruno Frediani⁸, Rosario Foti⁹, Fabrizio Conti¹⁰, Marco Sebastiani¹¹, Maria Sole Chimenti¹², Roberta Ramonda¹³, Fabiola Atzeni¹⁴, Maurizio Rossini¹⁵, Serena Bugatti¹⁶, Serena Guiducci¹⁷, Giovanni Lapadula¹, Gianfranco Ferraccioli¹⁸, Francesca Romana Spinelli¹⁰, Elisa Gremese¹⁹. | ¹Rheumatology Unit, DiMePReJ, University of Bari, Bari; ²Rheumatology Unit, Department of Medical and Surgical Sciences, Azienda Ospedaliero-Universitaria Policlinico Riuniti, Foggia; ³Rheumatology Unit, Martina Franca Hospital; ⁴Rheumatology Unit, ASL BT, P.O. Barletta; ⁵Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia; ⁶Rheumatology Unit, Department of Medical Science and Public Health, University of Cagliari, Monserrato (CA); ⁷Rheumatology Unit, Dipartimento di Reumatologia e Scienze Mediche, ASST PINI-CTO, University of Milano, Milano; ⁸Rheumatology Unit, Azienda Ospedaliero Universitaria Senese, Siena; ⁹Rheumatology Unit, A.O.U. Policlinico S. Marco, Catania; ¹⁰Rheumatology Unit, Department of Clinical Internal, Anesthesiologic and CV Sciences, Sapienza University of Rome, Roma; ¹¹Rheumatology Unit, AUSL Piacenza, University of Parma, Parma; ¹²Rheumatology, Department of Systems Medicine, University of Rome Tor Vergata, Roma; ¹³Rheumatology Unit, DIMED, University of Padua, Padova; ¹⁴Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina, Messina; ¹⁵Rheumatology Unit, Department of Medicine, University of Verona, Verona; ¹⁶Division of Rheumatology, Dept. of Internal Medicine and Therapy, Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia; ¹⁷Division of Rheumatology, Department of Experimental and Clinical Medicine, University of Firenze, Firenze; ¹⁸Department of Medicine, Catholic University of the Sacred Heart, Fondazione Policlinico Gemelli IRCCS, Roma; ¹⁹Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Humanitas University, Rozzano (MI), Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2000

  179

• PO:06:081 | Safety of JAK inhibitors compared to non-TNF-targeted biologic therapies in rheumatoid arthritis patients who are inadequate responders to TNF inhibitors Lorenzo Di Luozzo¹, Alessandro Giollo¹, Mariangela Salvato¹, Francesca Frizzera¹, Kiren Khalid¹, Margherita Zen¹, Andrea Doria¹ | ¹Azienda ospedaliera universitaria di Padova, unità di Reumatologia, Padova, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2298

  29

• CO:05:2 | An OMERACT study for the development of an algorithm for automatic identification of calcium pyrophosphate deposition by ultrasound: the Crystal Artificial Intelligence Monitoring Study Daniele Cirillo¹, Tito Bassani², Silvia Sirotti^1|2, Greta Pellegrino^1|2, Alessandro Lucia¹, Rodolfo Fabbri¹, Laura Pezzoni¹, Piercarlo Sarzi Puttini^1|2, Georgios Filippou^1|2. | ¹Università degli Studi di Milano; ²IRCCS Ospedale Galeazzi - Sant'Ambrogio, Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1971

  182

• PO:03:044 | Impact of Inflammatory Bowel Disease on Clinical Phenotype and Treatment Response in Patients with Psoriatic Arthritis Maria Morrone¹, Maria Giannotta¹, Vincenzo Venerito¹, Greta Giulia Dipietrangelo¹, Stefano Stano¹, Florenzo Iannone¹, Giuseppe Lopalco¹ | ¹Department of Precision and Regenerative Medicine and Ionian Area DiMePRe-J University of Bari, Bari, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2294

  27

• PO:06:079 | Weighing the burden: how body mass index shapes clinical outcomes in rheumatoid arthritis. Insights from a large Italian cohort Marco Capodiferro¹, Marco Fornaro¹, Gian Luca Erre², Matteo Piga³, Elena Bartoloni Bocci⁴, Andreina Manfredi⁵, Ennio Giulio Favalli⁶, Maria Sole Chimenti⁷, Serena Guiducci⁸, Eleonora Celletti⁹, Addolorata Corrado¹⁰, Alessandro Giollo¹¹, Simone Parisi¹², Ivan Giovannini¹³, Elisa Gremese¹⁴, Garifallia Sakellariou¹⁵, Ombretta Viapiana¹⁶, Fabiola Atzeni¹⁷, Francesca Romana Spinelli¹⁸, Fabio Cacciapaglia^1|19. | ¹Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area DiMePRe-J University of Bari, Bari, Italy; ²Dipartimento di Scienze Mediche, Chirurgiche e Sperimentali, Università degli Studi di Sassari, Sassari, Italy; ³Rheumatology Unit, AOU Cagliari, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy; ⁴Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy; ⁵Rheumatology Unit, Azienda Ospedaliera Universitaria Policlinico of Modena, Modena, Italy; ⁶Dpt of Rheumatology, G. Pini Institute, Milano, Italy; ⁷Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; ⁸Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Firenze, Italy; ⁹Rheumatology Unit, SS Annunziata Hospital, Chieti, Italy; ¹⁰Rheumatology Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy; ¹¹Rheumatology Unit, Department of Medicine, University of Padova Hospital Trust, Padova, Italy; ¹²Rheumatology Department, A.O.U. Città della Salute e della Scienza, Torino, Italy; ¹³Rheumatology Department, Santa Maria della Misericordia Hospital, Udine, Italy; ¹⁴Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Rozzano (MI), Italy; ¹⁵Department of Internal Medicine and Therapeutics, University of Pavia, Istituti Clinici Scientifici Maugeri, Pavia, Italy; ¹⁶Rheumatology Unit, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy; ¹⁷Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina, Messina, Italy; ¹⁸Reumatology Unit, Department of Internal, Anesthesiological, and Cardiovascular Clinical Sciences, Sapienza University, Roma, Italy; ¹⁹Miulli General Hospital Acquaviva - Department of Medicine and Surgery, LUM F. De Gennaro University, Casamassima (BA), Acquaviva delle Fonti (BA), Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2014

  152

• PO:36:252 | Long-Term Outcomes of Patients with Takayasu Arteritis in the Era of Biological Agents: a Multicenter International Study Alessandro Tomelleri¹, Durga Prasanna Misra², Fatma Alibaz-Oner³, Chiara Marvisi⁴, Chiara Calabrese¹, Upendra Rathore², Aysegul Avcu³, Adele Del Giudice⁴, Elisabetta Olivi⁴, Caterina Ricordi⁴, Corrado Campochiaro¹, Elena Baldissera¹, Marco Matucci-Cerinic¹, Haner Direskeneli³, Carlo Salvarani⁴, Lorenzo Dagna¹ | ¹IRCCS Ospedale San Raffaele, Unità di Immunologia, Reumatologia, Allergologia e Malattie Rare Milano, Italy; ²Sanjay Gandhi Postgraduate Institute of Medical Sciences SGPGIMS, Clinical Immunology and Rheumatology Lucknow Country, India; ³Marmara University, School of Medicine, Department of Internal Medicine, Division of Rheumatology Istanbul, Turkey; ⁴Azienda USL-IRCCS di Reggio Emilia, Unità di Reumatologia Reggio Emilia, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2389

  19

• PO:02:016 | Real-world evidence of upadacitinib over two years in Italian patients with axial spondyloarthritis Mariagrazia Lorenzin¹, Giacomo Cozzi¹, Stefano Gentileschi², Michele Maria Luchetti Gentiloni³, Antonio Carletto⁴, Maria Sole Chimenti⁵, Maria Manara⁶, Luca Quartuccio⁷, Rosario Foti⁸, Salvatore D'Angelo⁹, Ariela Hoxha¹⁰, Carlo Selmi¹¹, Bernd Raffeiner¹², Alessandro Giollo¹, Alberto Cauli¹³, Carlo Salvarani¹⁴, Fabiola Atzeni¹⁵, Roberta Ramonda¹, Sir Study Group Spa E Psa Antonio Spadaro¹⁶. | ¹Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy; ²Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy; ³Clinica Medica, Ospedali Riuniti Ancona University Hospital, Ancona; Department of Clinical and Molecular Sciences, Ancona, Italy; ⁴Rheumatology Unit, Department of Medicine, AOUI University of Verona, Verona, Italy; ⁵Rheumatology, allergology and clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Roma, Italy; ⁶Humanitas San Pio X, Milano, Italy; ⁷University of Udine, Academic Hospital Santa Maria della Misericordia, Udine, Italy; ⁸Rheumatology Unit, A.O.U. Policlinico S. Marco, Catania, Italy; ⁹Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza, Italy; ¹⁰Internal Medicine Unit, Thrombotic and Hemorrhagic Center, Department of Medicine-DIMED, University of Padua, Padova, Italy; ¹¹Department of Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy; ¹²Department of Rheumatology, Teaching Hospital of the Paracelsius Medical Hospital of Bolzano ASAA-SABES, Bolzano, Italy; ¹³Rheumatology Unit, Department of Medical Sciences, AOU and University of Cagliari, Monserrato, Cagliari, Italy; ¹⁴Department of Rheumatology, Azienda USL-IRCCS di Reggio Emilia and Università di Modena and Reggio Emilia, Reggio Emilia, Italy; ¹⁵Rheumatology Unit, University of Messina, Messina, Italy; ¹⁶Società Italiana di Reumatologia, Milano, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2007

  160

• PO:35:218 | Switching the dose of mepolizumab in patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European retrospective multicentre real-world study Edoardo Biancalana¹, Irene Mattioli¹, Emanuele Chiara², Danilo Malandrino¹, Maria Canfora¹, Palmerini Miki¹, Maria Paola Lisi¹, Michela Gasparotto³, Paola Tomietto³, Maria Letizia Urban¹, Giacomo Bagni¹, Elena Silvestri¹, Alessandra Bettiol³, Augusto Vaglio³, Giacomo Emmi² | ¹Department of Experimental and Clinical Medicine, University of Florence Firenze, Italy; ²Department of Medical, Surgery and Health Sciences, University of Trieste Trieste, Italy; ³Clinical Medicine and Rheumatology Unit, Cattinara University Hospital, Trieste, Trieste, Italy; ⁴Department of Biomedical, Experimental and Clinical Sciences Mario Serio, University of Florence Firenze, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2381

  18

• PO:26:087 | Rituximab versus glucocorticoids for IgG4-related disease: a European retrospective multi-center study of 167 patients Marco Lanzillotta¹, Jens Vikse², Elisabetta Goni³, Jasmin Mahajne¹, Veronica Batani¹, Lorenzo Dagna¹, Emanuel Della-Torre¹ | ¹Unit of Immunology, Rheumatology, Allergy, and Rare Disease, IRCCS Ospedale san Raffaele Milano, Italy; ²Department of Rheumatology, Stavanger University Hospital, Stavanger, Norway; ³Department of Medicine II, University Hospital, Ludwig Maximilian University Munich, Munich Germany

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2355

  46

• PO:04:050 | Cluster-Based Endotyping of Psoriatic Arthritis in a Monocentric Italian Cohort: A Real-World study Eneida Cela¹, Arianna D'Antonio¹, Luigi Fiannacca¹, Alberto Bergamini¹, Maxime Breban², Felicie Costantino², Maria Sole Chimenti¹ | ¹Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome Tor Vergata Rome, Italy; ²Rheumatology Department, AP-HP, Ambroise-Paré Hospital Paris, France

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2296

  8

• PO:05:069 | Risankizumab efficacy in peripheral and axial involvement: monocentric experience Roberta Foti¹, Ylenia Dal Bosco¹, Giorgio Amato¹, Elisa Visalli¹, Francesco De Lucia¹, Gabriella Paolí¹, Rosario Foti¹. | ¹UOSD Reumatologia AOU Policlinico G. Rodolico-S. Marco, Catania, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2012

  131

• PO:03:037 | The Impact of Peripheral Joint Involvement, Pain, and Inflammatory Bowel Diseases on Drug Persistence in Axial Psoriatic Arthritis Giuseppe Lopalco¹, Sergio Del Vescovo¹, Maria Sole Chimenti², Giuliana Guggino³, Serena Guiducci⁴, Eleonora Celletti⁵, Alberto Cauli⁶, Luca Cantarini⁷, Valentino Paci⁸, Eneida Cela², Lidia La Barbera³, Gemma Lepri⁴, Myriam Di Penta⁵, Alberto Floris⁶, Alice Agostinelli⁸, Vincenzo Venerito¹, Michele Maria Luchetti⁸, Florenzo Iannone¹ | ¹Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area, Bari, Italy; ²Reumatology, Allergology and Clinical Immunology University of Rome Tor Vergata, Roma, Italy; ³Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties, Palermo, Italy; ⁴Divisions of Internal Medicine and Rheumatology AOUC, Department of Experimental and Clinical Medicine, Firenze, Italy; ⁵Rheumatology Unit, SS. Annunziata Hospital of Chieti, G. D'Annunzio, Chieti, Italy; ⁶Department of Medical Science and Public Health, Cagliari, Italy; ⁷Policlinico Le Scotte, Siena, Italy; ⁸Clinical Medicine, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Ancona, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2292

  12

• PO:36:246 | Early real-world outcomes with benralizumab in eosinophilic granulomatosis with polyangiitis: a monocentric retrospective Richard Borrelli¹, Stefania Nicola¹, Federica Corradi¹, Iuliana Badiu¹, Marzia Boem¹, Valentina Marmora¹, Simone Negrini¹, Luisa Brussino¹. | ¹SCDU Immunologia e Allergologia, AO Mauriziano, Dipartimento di Scienze Mediche, Università degli Studi di Torino, Torino, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2094

  132

• PO:08:114 | The adjuvanted recombinant zoster vaccine is effective in preventing herpes zoster among patients ≥50 years of age with selected autoimmune diseases in the united states: a real-world database analysis (2018–2021) Rosaria Silvestri¹, Dagna Constenla², Germain Lonnet³, Emmanuel Aris³, Nathalie Servotte³, Ramsanjay Rk⁴, Agnes Mwakingwe-Omari², Huifeng Yun² | ¹GSK Verona, Italy; ²GSK Rockville, USA; ³GSK Wavre, Belgium; ⁴GSK Bengaluru, India

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2140

  149

• CO:01:1 | Efficacy and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study of 115 patients Marco Lanzillotta¹, Jens Vikse², Elisabetta Goni³, Veronica Batani¹, Jasmin Mahajne¹, Lorenzo Dagna¹, Emanuel Della Torre¹. | ¹Unit of Immunology, Rheumatology, Allergy, and Rare Disease, IRCCS Ospedale San Raffaele, Milano, Italy; ²Department of Rheumatology, Stavanger University Hospital, Norway; ³Department of Medicine II, University Hospital, Ludwig Maximilian University, Munich, Germany

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1961

  269

• S05:6 | Prevalence of osteoporosis and bone mineral metabolism disorders in an Italian cohort of patients with microcrystalline arthritis: results from the PREMIA observational study of the Italian Society of Rheumatology Silvia Grignaschi¹, Sonia Farah², Silvia Balduzzi¹, Bernd Raffeiner³, Carlomaurizio Montecucco⁴, Fausto Salaffi², Enrico Selvi⁵, Annamaria Iagnocco⁶, Fabiola Atzeni⁷, Serena Guiducci⁸, Rosario Foti⁹, Maria Manara¹⁰, Marcello Govoni¹¹, Carlo Selmi¹², Francesca Oliviero¹³, Roberta Ramonda¹³ | ¹ASST Pavia; ²Ospedale Carlo Urbani Jesi Italy; ³Azienda Sanitaria dell'Alto Adige, Bolzano; ⁴IRCCS Fondazione Policlinico San Matte, Pavia; ⁵AOU Senese, Siena; ⁶Ospedale MAuriziano, Torino; ⁷Università di Messina; ⁸AOU Careggi, Firenze; ⁹AOU Policlinico G. Rodolico, Catania; ¹⁰ASST Gaetano Pini-CTO Milano; ¹¹AUSL Ferrara; ¹²Humanitas San Pio X, Milano; ¹³AOU Padova, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2228

  126

• PO:12:178 | Don't count your chickens before they hatch! Analysis of cardiovascular definitions in studies on rheumatic diseases: a systematic literature review Laura Pezzoni¹, Silvia Sirotti^1|2, Georgios Filippou^1|2, Piercarlo Sarzi Puttini^1|2, Greta Pellegrino^1|2. | ¹Università degli Studi di Milano, Milano; ²IRCCS Ospedale Galeazzi Sant'Ambrogio, Milano, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2028

  136

• PO:31:169 | From Crisis to Chronicity: A Real-World Study of Renal Dysfunction in Systemic Sclerosis Stefano Stano¹, Fabio Cacciapaglia^1|2, Giorgia Campanale¹, Simone Perniola¹, Maria Morrone¹, Andrea Cito¹, Vincenzo Venerito¹, Maria Grazia Anelli¹, Giuseppe Lopalco¹, Florenzo Iannone¹ | ¹Rheumatology Unit - Department of Precision and Regenerative Medicine, Jonian Area DiPReMeJ, University of Bari Bari, Italy; ²Rheumatology Service, Internal Medicine Unit F. Miulli General Hospital, Department of Medicine and Surgery, LUM Casamassima, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2368

  16

• Assessment of liver and kidney function in patients with ankylosing spondylitis on long-term non-steroidal anti-inflammatory drug therapy

  S. Sülükcü, S. Uslu

  24-09-2024

  https://doi.org/10.4081/reumatismo.2024.1732

  3847

  PDF: 1046